Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: A comparison with other populations

Fenaux, 1996, Cytogenetics of myelodysplastic syndromes, Semin Hematol, 33, 127 Heaney, 1999, Myelodysplasia, N Eng J Med, 340, 1649, 10.1056/NEJM199905273402107 Germing, 2000, Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients, Leuk Res, 24, 983, 10.1016/S0145-2126(00)00088-6 Goasguen, 1992, Classification and morphologic features of myelodysplastic syndromes, Semin Oncol, 19, 4 Howe, 2004, The WHO classification of MDS does make a difference, Blood, 103, 3265, 10.1182/blood-2003-06-2124 Raynaud, 2003, Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes, Pathol Biol, 5, 346, 10.1016/S0369-8114(03)00111-1 Greenberg, 1997, International scoring system of evaluating prognosis in myelodysplastic syndromes, Blood, 89, 2079, 10.1182/blood.V89.6.2079 ISCN, 2005 Matsuda, 2005, Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes, Clin Trial Obs, 106, 2633 Lee, 2002, Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study, Cancer Genet Cytogenet, 132, 97, 10.1016/S0165-4608(01)00533-7 Irons, 2006, Prevalence of MDS subtypes in shanghai, China: a comparison of the World Health Organization and French American British classifications, Leuk Res, 30, 769, 10.1016/j.leukres.2005.10.018 Chen, 1995, Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries, Leukemia, 19, 767, 10.1038/sj.leu.2403688 Toyoma, 1993, Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicenter study in Japan, Leukemia, 7, 499 Komorkji, 2006, Myelodysplastic syndromes: a view where the sun rises and where the sun sets, Leuk Res, 30, 1067, 10.1016/j.leukres.2006.04.004 Haase, 2005, Correlation of cytogentic findings with morphology, clinical courses and prognosis in 2124 patients with MDS, Blood, 106, 787, 10.1182/blood.V106.11.787.787 Solé, 1992, Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes, Cancer Genet Cytogenet, 64, 12, 10.1016/0165-4608(92)90315-Y Panani, 2006, Cytogenetic aspects of adult primary myelodysplastic syndromes clinical implications, Cancer Lett, 235, 177, 10.1016/j.canlet.2005.04.011 Aktas, 2006, Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study, Cancer Genet Cytogenet, 171, 72, 10.1016/j.cancergencyto.2006.06.010 Mhawech, 2001, Myelodysplastic syndrome: review of cytogenetic and molecular data, Crit Rev Oncol Hematol, 40, 229, 10.1016/S1040-8428(01)00101-9 Lessard, 2007, Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukaemia actually differ?, Cancer Genet Cytogenet, 176, 1, 10.1016/j.cancergencyto.2007.01.013 Matsushima, 2003, Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia, Blood, 101, 3386, 10.1182/blood-2002-03-0947 Look, 2005, Molecular pathogenesis of MDS, Hematology, 156, 10.1182/asheducation-2005.1.156 United Kingdom Cancer Cytogenetics Group (UKCCG), 1992, Loss of the Y chromosome from normal and neoplastic bone marrows, Genes Chromosomes Cancer, 5, 83, 10.1002/gcc.2870050112 Wiktor, 2000, Clinical significance of Y chromosome loss in haematological disease, Genes Chromosomes Cancer, 27, 11, 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I Babicka, 2007, Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH, Leuk Res, 31, 39, 10.1016/j.leukres.2006.03.010 Solé, 2000, Incidence characterisation and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes, Br J Haematol, 346, 10.1046/j.1365-2141.2000.01868.x Elghetany, 2007, Myelodysplastic syndromes in children. A critical review of issues in the diagnosis and classification of 887 cases from 13 published series, Arch Pathol Lab Med, 131, 1110, 10.5858/2007-131-1110-MSICAC Chatterjee, 2005, Primary myelodysplastic syndrome in children-clinical, haematological and histomorphological profile from a tertiary care centre in India, Hematology, 10, 495, 10.1080/10245330500155556 Parlier, 1994, Hematologic, clinical and cytogenetic ananlysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings, Cancer Genet Cytogenet, 78, 219, 10.1016/0165-4608(94)90094-9 Pierre, 1989, Clinical-cytogenetic correlations in myelodysplasia (preleukemia), Cancer Genet Cytogenet, 40, 149, 10.1016/0165-4608(89)90021-6 Borgonovo, 2005, Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS), Genet Mol Biol, 28, 18, 10.1590/S1415-47572005000500002 Ma, 2007, Myelodysplastic syndromes: incidence and survival in the united states, Cancer, 109, 1536, 10.1002/cncr.22570 Jacobs, 1986, Prognostic implications of morphology and karyotype in primary myelodysplastiques syndromes, Blood, 67, 1765, 10.1182/blood.V67.6.1765.1765